Practical application of a chromogenic FXIIa assay

Biomaterials

Volumn 27, Issue 28, 2006, Pages 4840-4845

  Zhuo, Rui ^a   Vogler, Erwin A ^a,b  

^a Department of Bioengineering ^*  (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Autoactivation; Autohydrolysis; Blood coagulation; Factor XII; Hageman factor

Indexed keywords

BIOASSAY; BIOMATERIALS; BLOOD; CONCENTRATION (PROCESS); HYDROLYSIS; PLASMAS; PROTEINS;

AUTOACTIVATION; AUTOHYDROLYSIS; BLOOD COAGULATION; FACTOR XII; HAGEMAN FACTORS;

CHROMOGENICS;

BIOMATERIAL; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 12A; BLOOD CLOTTING FACTOR 13A; BUFFER;

ARTICLE; BIOASSAY; BIOCOMPATIBILITY; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TIME; CONCENTRATION PROCESS; HEMODYNAMICS; HUMAN; HYDROLYSIS; MEASUREMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; THROMBOCYTE POOR PLASMA;

BIOLOGICAL ASSAY; CHROMOGENIC COMPOUNDS; FACTOR XIIA; HUMANS; HYDROLYSIS; PLASMA; STATISTICS;

EID: 33744992039     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.05.008     Document Type: Article

References (25)

1. Rose E.A., Gelijns A.C., Moskowitz A., Heitjan D.F., Stevenson L.W., Dembitsky W., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345 20 (2001) 1435-1443
2. Lavine M., Roberts M., and Smith O. Bodybuilding: the bionic human. Science 295 (2002) 995-1032
3. Hanson S.R., and Harker L.A. Blood Coagulation and blood-materials interactions. In: Ratner B.D., Hoffman A.S., Schoen F.J., and Lemons J.E. (Eds). Biomaterials science: an introduction to materials in medicine (1996), Academic Press, San Diego 193-199
4. Colman R.W., and Schmaier A.H. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 90 10 (1997) 3819-3843
5. Samuel M., Pixley R., Villanueva M., Colman R., and Villanueva G. Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies. J Biol Chem 267 27 (1992) 19691-19697
6. Guo Z., Bussard K., Vogler E.A., and Siedlecki C.A. Mathematical modeling of material-induced blood plasma coagulation. Biomaterials 27 (2006) 796-806
7. Zhuo R., Miller R., Bussard K.M., Siedlecki C.A., and Vogler E.A. Procoagulant stimulus processing by the intrinsic pathway of blood plasma coagulation. Biomaterials 26 (2005) 2965-2973
8. Zhuo R., Colombo P., Pantano C., and Vogler E.A. Silicon oxycarbide glasses for blood-contact applications. Acta Biomaterial 1 (2005) 583-589
9. Vogler E.A., Graper J.C., Harper G.R., Lander L.M., and Brittain W.J. Contact activation of the plasma coagulation cascade. 1. Procoagulant surface energy and chemistry. J Biomed Mat Res 29 (1995) 1005-1016
10. Vogler E.A., Graper J.C., Sugg H.W., Lander L.M., and Brittain W.J. Contact Activation of the plasma coagulation cascade. 2. Protein adsorption on procoagulant surfaces. J Biomed Mater Res 29 (1995) 1017-1028
11. Vogler E.A., Nadeau J.G., and Graper J.C. Contact activation of the plasma coagulation cascade. 3. Biophysical aspects of thrombin binding anticoagulants. J Biomed Mater Res 40 1 (1997) 92-103
12. Brown B. Hematology: principles and procedures. 3rd ed (1980), Lea and Febiger, Philadelphia
13. Tripodi A., and Mannucci P.M. Clinical Evaluation of a fully automated chromogenic method for prothrombin time compared with a conventional coagulation method. Clin Chem 30 8 (1984) 1392-1395
14. Friberger P. Synthetic peptide substrate assays and fibrinolysis and their application on automates. Semin Thrombosis Haemostasis 9 4 (1983) 281-300
15. Kamp K.W.vd., Hauch K.D., Feijen J., and Horbett T.A. Contact activation during incubation of five different polyurethanes or glass in plasma. J Biomed Mater Res 29 10 (1995) 1303-1306
16. Ziats N.P., Panikowsky D.A., Tierney B.P., Ratnoff O.D., and Anderson J.M. Adsorption of hageman factor (factor XII) and other human plasma proteins to biomedical polymers. J Lab Clin Med 116 5 (1990) 687-696
17. Marata B.M., Courtney J.M., and Sundaram S. Determination of contact phase activation by the measurement of the activity of supernatant and membrand surface-adsorbed factor XII (FXII): its relevance as a useful parameter for the in vitro assessment of haemodialysis membrane. J Biomed Mater Res 31 (1996) 63-70
18. Grunkemeier J.M., Tsai W.B., and Horbett T.A. Hemocompatibility of treated polystyrene substrates. J Biomed Mater Res 41 4 (1998) 657-670
19. Groth T., Synowitz J., Richay K., Albercht W., Lange K.-P., et al. Contact activation of plasma coagulation on polymeric membranes measured by the activity of Kallikrein in heparanized plasma. J Biomater Sci Polym Edn 8 10 (1997) 797-807
20. Anderson N.L., and Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1 11 (2002) 845-867
21. Saito H, Ratnoff OD, Pensky J. Radioimmunoassay of human Hageman factor (factor XII). J Lab Clin Med 1976;88(3):506-14.
22. Zhuo R., Siedlecki C.A., and Vogler E.A. Autoactivation of blood factor XII at hydrophilic and hydrophobic surfaces. Biomaterials 27 (2006) 4325-4332
23. Tans G., and Rosing J. Structural and functional characterization of factor XII. Semin Thromb Hemostasis 13 1 (1987) 1987
24. Asmis L.M., Sulzer I., Furlan M., and Lammle B. Prekallikrein deficiency: the characteristic normalization of the severely prolonged aPTT following increased preincubation time is due to autoactivation of factor XII. Thrombosis Res 105 (2002) 463-470
25. Tans G., Rosing J., and Griffin J.H. Sulfatide-dependent autoactivation of human blood coagulation factor XII (Hageman Factor). J Biol Chem 258 13 (1983) 8215-8222